 |
 Video: What is a Stock Split?
|
|
|
| Anixa Biosciences is a biotechnology company. Co.'s vaccine programs include: the development of a preventative vaccine against triple negative breast cancer and other forms of breast cancer; and the development of a preventative vaccine against ovarian cancer. Co.'s therapeutics programs include: the development of a chimeric endocrine receptor T-cell therapy, a form of chimeric antigen receptor T-cell technology, initially focused on treating ovarian cancer, which is being developed at its subsidiary, Certainty Therapeutics, Inc.; and the development of anti-viral drug candidates for the treatment of Coronavirus disease 2019 focused on inhibiting certain protein functions of the virus. According to our Anixa Biosciences stock split history records, Anixa Biosciences has had 0 splits. | |
|
Anixa Biosciences (ANIX) has 0 splits in our Anixa Biosciences stock split history database.
Looking at the Anixa Biosciences stock split history from start to finish, an original position size of 1000 shares would have turned into 1000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Anixa Biosciences shares, starting with a $10,000 purchase of ANIX, presented on a split-history-adjusted basis factoring in the complete Anixa Biosciences stock split history.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
05/06/2014 |
|
| End date: |
05/03/2024 |
|
| Start price/share: |
$0.38 |
|
| End price/share: |
$2.94 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
673.68% |
|
| Average Annual Total Return: |
22.70% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$77,347.38 |
|
| Years: |
10.00 |
|
|
|
|
|
